2017
The unique value of cardiovascular magnetic resonance in patients with suspected acute coronary syndrome and culprit-free coronary angiograms
PANOVSKÝ, Roman, Júlia BOROVA, Martin PLEVA, Věra FEITOVÁ, Petr NOVOTNÝ et. al.Základní údaje
Originální název
The unique value of cardiovascular magnetic resonance in patients with suspected acute coronary syndrome and culprit-free coronary angiograms
Autoři
PANOVSKÝ, Roman (203 Česká republika, garant, domácí), Júlia BOROVA (203 Česká republika), Martin PLEVA (203 Česká republika), Věra FEITOVÁ (203 Česká republika, domácí), Petr NOVOTNÝ (203 Česká republika, domácí), Vladimír KINCL (203 Česká republika, domácí), Tomáš HOLEČEK (203 Česká republika, domácí), Jaroslav MELUZÍN (203 Česká republika, domácí), Ondřej SOCHOR (203 Česká republika, domácí) a Radka STEPANOVA (203 Česká republika)
Vydání
BMC Cardiovascular Disorders, London, Biomed Central Ltd, 2017, 1471-2261
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30201 Cardiac and Cardiovascular systems
Stát vydavatele
Velká Británie a Severní Irsko
Utajení
není předmětem státního či obchodního tajemství
Impakt faktor
Impact factor: 1.812
Kód RIV
RIV/00216224:14110/17:00097375
Organizační jednotka
Lékařská fakulta
UT WoS
000404716400001
Klíčová slova anglicky
Cardiac magnetic resonance; Acute coronary syndrome; Normal coronary angiography
Štítky
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 20. 3. 2018 12:38, Soňa Böhmová
Anotace
V originále
Background: Patients with chest pain, elevated troponin, and unobstructed coronary disease present a clinical dilemma. The purpose of this study was to investigate the incremental diagnostic value of cardiovascular magnetic resonance (CMR) in a cohort of patients with suspected acute coronary syndrome (ACS) and unobstructed coronary arteries. Results: Data files of patients meeting the inclusion criteria in two cardiology centres were searched and analysed. The inclusion criteria included: 1) thoracic pain suspected with ACS; 2) a significant increase in the high-sensitive Troponin T value; 3) ECG changes; 4) coronary arteries without any significant stenosis; 5) a CMR examination included in the diagnostic process; 6) an uncertain diagnosis before the CMR exam; and 7) the absence of known CMR and contrast media contraindications. Special attention was paid to the benefits of CMR in determining the final diagnosis. In total, 136 patients who underwent coronary angiography for chest pain were analysed. The most frequent underlying causes were myocarditis (38%) and perimyocarditis (18%), followed by angiographically unrecognised acute myocardial infarction (18%) and Takotsubo cardiomyopathy (15%). The final diagnosis remained unclear in 6% of the patients. The contribution of CMR in determining the final diagnosis determination was crucial in 57% of the patients. In another 35% of the patients, CMR confirmed the suspicion and, only 8% of the CMR examinations did not help at all and had no influence on diagnosis or treatment. Conclusion: CMR provided a powerful incremental diagnostic value in the cohort of patients with suspected ACS and unobstructed coronary arteries. CMR is highly recommended to be incorporated as an inalienable part of the diagnostic algorithms in these patients.